The bronchodilator response and clinical characteristics of patients with bronchiectasis
W. Goh (Singapore , Singapore), E. Tan (Singapore , Singapore), X. Wang (Singapore , Singapore), P. Quek (Singapore , Singapore), L. Tham (Singapore , Singapore), L. Tan (Singapore , Singapore), J. Abisheganaden (Singapore , Singapore), A. Lim (Singapore , Singapore)
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Session: Phenotypes and endotypes of bronchiectasis
Session type: Thematic Poster
Number: 2874
Disease area: Airway diseases, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Goh (Singapore , Singapore), E. Tan (Singapore , Singapore), X. Wang (Singapore , Singapore), P. Quek (Singapore , Singapore), L. Tham (Singapore , Singapore), L. Tan (Singapore , Singapore), J. Abisheganaden (Singapore , Singapore), A. Lim (Singapore , Singapore). The bronchodilator response and clinical characteristics of patients with bronchiectasis. 2874
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Evaluation of the individual bronchodilator response in patients with severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020
Evaluation of bronchodilator responses in patients with advanced COPD Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001
Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006
Differences in clinical and inflammatory characteristics between steroid-withdrawal-induced and spontaneous exacerbations in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 199s Year: 2002
Clinical value of the immediate bronchodilator response to diagnose asthma in steroid-naïve adults Source: International Congress 2019 – Clinical implications of asthma management Year: 2019
Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001
Analysis of bronchodilator response in patients with controlled asthma Source: Eur Respir J 2004; 24: Suppl. 48, 223s Year: 2004
Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012
How the bronchodilatator in COPD patients works Source: Eur Respir J 2004; 24: Suppl. 48, 288s Year: 2004
Acute bronchodilator response does not predict health outcomes in patients with COPD treated with tiotropium Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009
The effect of maintenance azithromycin on radiological features in patients with bronchiectasis Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019
Microbiological and inflammatory characteristics of exacerbations in COPD patients with comorbid radiographic bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019
Clinical value of bronchodilator response for diagnosing asthma in steroid-naïve adults Source: ERJ Open Res, 7 (4) 00293-2021; 10.1183/23120541.00293-2021 Year: 2021
Assessment of maximal airway response before and after inhaled corticosteriod treatment in new diagnosed asthma patients Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007
Comparison of clinical characteristics between stable COPD patients with- and without mild bronchiectasis Source: Eur Respir J 2002; 20: Suppl. 38, 257s Year: 2002
Magnetocardiographic assessment of therapeutic efficacy of β2–agonists and corticosteroids in patients with COPD and bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Evaluating acute bronchodilator response with subjective and objective criteria in stable COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 64s Year: 2005
The role of response to bronchodilators in differential diagnosis of COPD and asthma Source: Eur Respir J 2003; 22: Suppl. 45, 424s Year: 2003